UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gut, inflammation and osteoporosis: basic and clinical concepts

Gut, 2008-05, Vol.57 (5), p.684-694

2008

Volltextzugriff (PDF)

Adiponectin: key player in the adipose tissue-liver crosstalk

Current medicinal chemistry, 2012-11, Vol.19 (32), p.5467-5473

2012

Volltextzugriff (PDF)

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

Gut, 2005-04, Vol.54 (4), p.479-487

2005

Volltextzugriff (PDF)

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Volltextzugriff (PDF)

Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients

Journal of Crohn's and colitis, 2021-01, Vol.15 (1), p.88-98

2021

Volltextzugriff (PDF)

The role of apolipoprotein A5 in non-alcoholic fatty liver disease

Gut, 2011-07, Vol.60 (7), p.985-991

2011

Volltextzugriff (PDF)

Liver Complications in Inflammatory Bowel Diseases

Digestive diseases (Basel), 2013-01, Vol.31 (2), p.233-238

2013

Volltextzugriff (PDF)

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease

Clinical immunology (Orlando, Fla.), 2004-10, Vol.113 (1), p.47-55

2004

Volltextzugriff (PDF)

Effect of weight loss on heme oxygenase-1 tissue expression

Diabetes & metabolism, 2017-09, Vol.43 (4), p.389-391

2017

Volltextzugriff (PDF)

Adipose type I interferon signalling protects against metabolic dysfunction

Journal of hepatology, 2017, Vol.66 (1), p.S609-S609

2017

Volltextzugriff (PDF)

Targeting T and B Lymphocytes in Inflammatory Bowel Diseases: Lessons from Clinical Trials

Digestive diseases (Basel), 2013-01, Vol.31 (3-4), p.328-335

2013

Volltextzugriff (PDF)

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis

Journal of internal medicine, 2005-09, Vol.258 (3), p.274-280

2005

Volltextzugriff (PDF)

Sustainable development of communities: ISO 37120 and UN goals

International journal of sustainability in higher education, 2019-07, Vol.20 (5), p.887-900

2019

Volltextzugriff (PDF)

Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology

Zeitschrift fur Gastroenterologie, 2014-02, Vol.52 (2), p.204

2014

Volltextzugriff (PDF)

Increased expression of CCL20 in human inflammatory bowel disease

Journal of Clinical Immunology, 2004-01, Vol.24 (1), p.74-85

2004

Volltextzugriff (PDF)

P206 Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i527-i527

2024

Volltextzugriff (PDF)

Eotaxin-3 in Churg―Strauss syndrome: a clinical and immunogenetic study

Rheumatology (Oxford, England), 2011-10, Vol.50 (10), p.1823-1827

2011

Volltextzugriff (PDF)

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways

Immunity (Cambridge, Mass.), 2011-01, Vol.34 (1), p.61-74

2011

Volltextzugriff (PDF)

O-128 Intra-cycle alterations of the uterine microbiota in patients with recurrent miscarriage or recurrent implantation failure and healthy controls

Human reproduction (Oxford), 2021-08, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor expression

Gut, 2010-09, Vol.59 (9), p.1259-1264

2010

Volltextzugriff (PDF)

Adiponectin and its Receptors as Potential Therapeutical Targets

Immunology, endocrine & metabolic agents in medicinal chemistry, 2007-04, Vol.7 (2), p.107-114

2007

Volltextzugriff (PDF)

P917 Intestinal complement interacts with commensal microbiota and provides pattern recognition in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i1027-i1027

2023

Volltextzugriff (PDF)

P905 Symptomatic remission and IUS improvements in a multi-national real-world cohort of UC patients treated with Upadacitinib - First results from the IBD-DACH study EUROPE

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1657-i1657

2024

Volltextzugriff (PDF)

P809 VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1506-i1507

2024

Volltextzugriff (PDF)

Adiponectin and its receptors in non-alcoholic steatohepatitis

Gut, 2005-01, Vol.54 (1), p.117-121

2005

Volltextzugriff (PDF)

1 – 25 von 593

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(465)
Mit Volltextzugriff
(440)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Gut, inflammation and osteoporosis: basic and clinical concepts

Adiponectin: key player in the adipose tissue-liver crosstalk

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients

The role of apolipoprotein A5 in non-alcoholic fatty liver disease

Liver Complications in Inflammatory Bowel Diseases

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease

Effect of weight loss on heme oxygenase-1 tissue expression

Adipose type I interferon signalling protects against metabolic dysfunction

Targeting T and B Lymphocytes in Inflammatory Bowel Diseases: Lessons from Clinical Trials

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis

Sustainable development of communities: ISO 37120 and UN goals

Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology

Increased expression of CCL20 in human inflammatory bowel disease

P206 Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease

Eotaxin-3 in Churg―Strauss syndrome: a clinical and immunogenetic study

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways

O-128 Intra-cycle alterations of the uterine microbiota in patients with recurrent miscarriage or recurrent implantation failure and healthy controls

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor expression

Adiponectin and its Receptors as Potential Therapeutical Targets

P917 Intestinal complement interacts with commensal microbiota and provides pattern recognition in Inflammatory Bowel Disease

P905 Symptomatic remission and IUS improvements in a multi-national real-world cohort of UC patients treated with Upadacitinib - First results from the IBD-DACH study EUROPE

P809 VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland

Adiponectin and its receptors in non-alcoholic steatohepatitis

Suchergebnisse filtern